UnitedHealth Group Incorporated (NYSE:UNH) updated its FY17 earnings guidance on Tuesday. The company provided EPS guidance of $9.75-9.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.80.
Several research firms recently weighed in on UNH. Jefferies Group LLC restated a buy rating and set a $192.00 price target on shares of UnitedHealth Group in a report on Friday, May 19th. Vetr lowered UnitedHealth Group from a buy rating to a hold rating and set a $179.00 price target on the stock. in a report on Monday, April 24th. Cantor Fitzgerald reiterated an overweight rating and issued a $205.00 target price (up previously from $200.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Zacks Investment Research upgraded UnitedHealth Group from a hold rating to a buy rating and set a $201.00 target price on the stock in a research note on Wednesday, June 7th. Finally, Barclays PLC increased their target price on UnitedHealth Group from $200.00 to $217.00 and gave the stock an overweight rating in a research note on Wednesday, July 19th. One equities research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. The company presently has a consensus rating of Buy and a consensus target price of $200.24.
UnitedHealth Group Incorporated (NYSE:UNH) opened at 194.88 on Monday. The company’s 50-day moving average price is $186.80 and its 200 day moving average price is $173.05. The stock has a market capitalization of $191.96 billion, a PE ratio of 23.41 and a beta of 0.64. UnitedHealth Group Incorporated has a 12 month low of $132.39 and a 12 month high of $196.04.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same period in the prior year, the business posted $1.96 earnings per share. UnitedHealth Group’s revenue for the quarter was up 7.7% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.
In other news, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the transaction, the director now directly owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the transaction, the director now directly owns 76,058 shares in the company, valued at $14,753,730.84. The disclosure for this sale can be found here. Insiders sold 15,540 shares of company stock worth $2,873,320 over the last ninety days. 0.89% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Issues FY17 Earnings Guidance” was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://stocknewstimes.com/2017/08/07/unitedhealth-group-incorporated-unh-issues-fy17-earnings-guidance-updated-updated.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
